Kalka Institute for Research and Advanced Studies D Pharma : Fees, Courses, Eligibility & Admission 2025

Kalka Institute for Research and Advanced Studies D Pharma is a 2 Years year program. The eligibility criteria for the Diploma in Pharmacy degree at Kalka Group Of Institutions in India require candidates to have completed their 10+2 education in the science stream with a minimum aggregate score of 50%. Additionally, students must have studied Physics, Chemistry, and Biology as compulsory subjects in their higher secondary education. It is also necessary for candidates to have obtained a valid score in relevant entrance exams such as the state-level or national-level pharmacy entrance examinations. Meeting these eligibility criteria will enable students to pursue the Diploma in Pharmacy program at Kalka Group Of Institutions and embark on a rewarding career in the pharmaceutical industry. The annual fee for D Pharma is INR 60,000. More details about eligibility criteria, fees, admission process, selection criteria, application fees, how to apply, and important dates for Kalka Institute for Research and Advanced Studies D Pharma admission are given below:

Kalka Group Of Institutions D Pharma is a 2 Years programme offered in specializations like Pharmacy. Kalka Group Of Institutions D Pharma admission 2025 will be based on NEET, GPAT.

The eligibility criteria for the Diploma in Pharmacy degree at Kalka Group Of Institutions in India require candidates to have completed their 10+2 education in the science stream with a minimum aggregate score of 50%. Additionally, students must have studied Physics, Chemistry, and Biology as compulsory subjects in their higher secondary education. It is also necessary for candidates to have obtained a valid score in relevant entrance exams such as the state-level or national-level pharmacy entrance examinations. Meeting these eligibility criteria will enable students to pursue the Diploma in Pharmacy program at Kalka Group Of Institutions and embark on a rewarding career in the pharmaceutical industry.